✓
Open
4 Aug 2023
✓
Close
8 Aug 2023
3
Allotment
—
✓
Listing
Fri, Aug 18, 2023
Price Band
₹705 to ₹741
Issue Size
2,09,25,652 shares (agg. up to ₹1,551 Cr)
Lot Size
20 Shares
Listing Date
Fri, Aug 18, 2023
Latest GMP
₹122
Est. Gain
16.46%
✦ AI Insight
GMP Trend
18-08-2023₹122Est. ₹863+16.46%
17-08-2023₹122Est. ₹863+16.46%
16-08-2023₹122Est. ₹863+16.46%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 17.64x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 1,513.98 | 1,312.80 | 1,182.55 |
| Total Income | 888.48 | 736.35 | 630.75 |
| Profit After Tax | 240.08 | 174.93 | 234.89 |
| NET Worth | 1,290.00 | 1,103.22 | 999.37 |
| Total Borrowing | 31.24 | 60.59 | 86.35 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,309.00 |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹59.75 |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹912.75 |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹277.45 |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹90.05 |
| Trident Lifeline Ltd. | SME | ₹35.34 Cr | ₹101 | 51.53 | ₹108.15 | +7.08% | ₹287.50 |
| Dipna Pharmachem Ltd. | SME | ₹15.21 Cr | ₹38 | 39 | ₹33.40 | -12.11% | ₹4.98 |
| JFL Life Sciences Ltd. | SME | ₹18.17 Cr | ₹61 | 26.52 | ₹66.50 | +9.02% | ₹9.70 |
About Concord Biotech IPO
Updated on Aug 5, 2026
Contact Details
Concord Biotech Ltd. Address1482-86, Trasad Road DholkaAhmedabad, Gujarat, 382225079-6813 8700complianceofficer@concordbiotech.comVisit Website